Novo Nordisk
NVO
#25
Rank
โ‚น33.466 T
Marketcap
โ‚น7,630
Share price
1.68%
Change (1 day)
-21.90%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): โ‚น235.77

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is โ‚น249.96. In 2022 the company made an earnings per share (EPS) of โ‚น189.97 an increase over its 2021 EPS that were of โ‚น174.27.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น235.7724.11%
2022โ‚น189.979.01%
2021โ‚น174.2715.08%
2020โ‚น151.4314.83%
2019โ‚น131.87-1.68%
2018โ‚น134.134.96%
2017โ‚น127.7931.08%
2016โ‚น97.49-10.33%
2015โ‚น108.7213.91%
2014โ‚น95.444.03%
2013โ‚น91.75-28.81%
2012โ‚น128.87108.9%
2011โ‚น61.6925.59%
2010โ‚น49.1235.01%
2009โ‚น36.38-9.17%
2008โ‚น40.0561.35%
2007โ‚น24.8228.96%
2006โ‚น19.2525.63%
2005โ‚น15.324.17%
2004โ‚น14.7113.55%
2003โ‚น12.9536.87%
2002โ‚น9.46-6.99%
2001โ‚น10.1821.56%
2000โ‚น8.3749.45%
1999โ‚น5.603.78%
1998โ‚น5.4012.15%
1997โ‚น4.8124.74%
1996โ‚น3.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น162.81-34.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น475.23 90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น347.49 39.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น278.37 11.36%๐Ÿ‡ซ๐Ÿ‡ท France